$46.39 -0.42 (%) Sanofi Shs Sponsored American Deposit Receipt Repr 1/2 Sh - NYSE

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults

    Benzinga | Dec. 12, 2014 | 08:04AM EST
  2. Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO

    Benzinga | Dec. 9, 2014 | 15:02PM EST
  3. Two Gauges That Point To Fund Buying In A Stock

    IBD | Dec. 8, 2014 | 18:18PM EST
  4. Merck Acquiring Cubist, Focusing On Hospital Care

    IBD | Dec. 8, 2014 | 11:48AM EST
  5. Mid-Day Market Update: ON Semiconductor Surges On $1 Billion Buyback Plan; POZEN Shares Slip

    Benzinga | Dec. 1, 2014 | 13:43PM EST
  6. Mid-Morning Market Update: Markets Open Lower; Weatherford To Sell Engineered Chemistry, Drilling Fluid Operations to Berkshire's Lubrizol

    Benzinga | Dec. 1, 2014 | 10:23AM EST
  7. Morning Market Losers

    Benzinga | Dec. 1, 2014 | 09:53AM EST
  8. Pharma drugs advance in EU

    IBD | Nov. 21, 2014 | 18:19PM EST
  9. AbbVie, Celgene, Sanofi Drugs Get EU Endorsements

    IBD | Nov. 21, 2014 | 12:28PM EST
  10. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD | Nov. 20, 2014 | 11:44AM EST
  11. Asthma treatment passes trial

    IBD | Nov. 11, 2014 | 18:30PM EST
  12. Guru Stocks at 52-Week Lows: IBM, SNY, SAN, RIO, E

    GuruFocus | Nov. 9, 2014 | 01:58AM EST
  13. Guru Stocks at 52-Week Lows: IBM, BBL, SNY, SAN, RIO

    GuruFocus | Nov. 4, 2014 | 14:23PM EST
  14. Benzinga's M&A Chatter for Thursday October 30, 2014

    Benzinga | Oct. 30, 2014 | 21:24PM EST
  15. CNBC's Stock Pops & Drops From October 29

    Benzinga | Oct. 29, 2014 | 20:29PM EST
  16. Sanofi fires CEO, downgraded

    IBD | Oct. 29, 2014 | 18:41PM EST
  17. Sanofi Axes CEO, Hit By Multiple Downgrades

    IBD | Oct. 29, 2014 | 12:51PM EST
  18. Deutsche Bank Downgrades Sanofi SA

    Benzinga | Oct. 29, 2014 | 12:29PM EST
  19. Mid-Morning Market Update: Markets Mixed; Goodyear Earnings Beat Estimates

    Benzinga | Oct. 29, 2014 | 10:43AM EST
  20. Sanofi Warns Of Flat Growth

    IBD | Oct. 28, 2014 | 18:46PM EST
  21. Markets Continue To Rally As The Dow Closes Above 17,000

    Benzinga | Oct. 28, 2014 | 16:44PM EST
  22. Mid-Afternoon Market Update: Dow Rises Over 150 Points; Kohl's Shares Decline On Weak Forecast

    Benzinga | Oct. 28, 2014 | 15:39PM EST
  23. French Drugmaker Sanofi Warns Of Tougher Competition

    IBD | Oct. 28, 2014 | 14:42PM EST
  24. Mid-Day Market Update: Integrated Device Technology Jumps On Upbeat Earnings; Twitter Shares Decline

    Benzinga | Oct. 28, 2014 | 13:50PM EST
  25. Midday Losers From October 28: Twitter, Kohl's, Amkor Technologies And More

    Benzinga | Oct. 28, 2014 | 13:27PM EST
  26. Mid-Morning Market Update: Markets Open Higher; Pfizer Profit Tops Street View

    Benzinga | Oct. 28, 2014 | 11:06AM EST
  27. Report: Actavis, Sanofi To Bid On Over-The-Counter Drug Maker

    Benzinga | Oct. 20, 2014 | 20:15PM EST
  28. Benzinga's M&A Chatter for Monday October 20, 2014

    Benzinga | Oct. 20, 2014 | 19:27PM EST
  29. Illumina Helps Make Gene Sequencing Affordable

    IBD | Oct. 17, 2014 | 18:48PM EST
  30. Regeneron's Eylea Tops Rivals

    IBD | Oct. 17, 2014 | 18:45PM EST
  31. Regeneron Eye Drug Beats Rivals While Amgen Sues

    IBD | Oct. 17, 2014 | 11:27AM EST
  32. Alnylam jumps on trial results

    IBD | Oct. 13, 2014 | 18:46PM EST
  33. Alnylam Drug Scores Against Rare Nerve Disease

    IBD | Oct. 13, 2014 | 13:59PM EST
  34. Illumina Pads Gene Sequencing Lead With Pharma Deals

    IBD | Oct. 8, 2014 | 16:04PM EST
  35. Eurozone Exports Gear Up For Currency Advantage

    IBD | Oct. 2, 2014 | 18:24PM EST
  36. Stocks Move To Session Lows; Regeneron Rises On Drug Data

    IBD | Sep. 30, 2014 | 15:04PM EST
  37. Biotech Stocks Rebound On Strong Earnings, New Drugs

    IBD | Sep. 29, 2014 | 18:32PM EST
  38. Multiple Sclerosis Drugs Could Transform Market Again

    IBD | Sep. 26, 2014 | 18:07PM EST
  39. NASDAQ Dips 1.5%; HB Fuller Shares Decline On Downbeat Results

    Benzinga | Sep. 25, 2014 | 12:09PM EST
  40. Markets Tumble; Scholastic Posts Wider Fiscal-First Quarter Loss

    Benzinga | Sep. 25, 2014 | 11:12AM EST
  41. International Securities For A Diversified Income Portfolio

    GuruFocus | Sep. 23, 2014 | 13:36PM EST
  42. Could European Funds Offer An Opportunity Now?

    Benzinga | Sep. 23, 2014 | 10:04AM EST
  43. Meet 5 Top International Stocks Not Based In China

    IBD | Sep. 22, 2014 | 19:43PM EST
  44. ReceptosMS Drug Yields More Good Data; Stock Jumps

    IBD | Sep. 10, 2014 | 11:58AM EST
  45. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD | Sep. 5, 2014 | 17:06PM EST
  46. ECB Decision Boosts ETFs

    Benzinga | Sep. 4, 2014 | 16:02PM EST
  47. Novartis, Regeneron Cardio Results Pump Up Wall St.

    IBD | Sep. 2, 2014 | 18:04PM EST
  48. Novartis, Regeneron Hit New Highs On Cardio Drugs

    IBD | Sep. 2, 2014 | 11:19AM EST
  49. Thin Gains Quickly Turn Mixed; Regeneron, Staples Surge Ahead

    IBD | Sep. 2, 2014 | 10:43AM EST
  50. Nasdaq, S&P 500 Rise In Lackluster Session; Tesla Gains

    IBD | Aug. 29, 2014 | 15:12PM EST
Trading Center